109 related articles for article (PubMed ID: 16999361)
21. [Study on the relationship of alteration and expression of p16 gene to pancreatic carcinoma].
Zhou J; Yang D; Zhang L; Wang J; Yao Q; Su Z; Fan Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec; 17(6):399-403. PubMed ID: 11110976
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
23. CDKN2/p16 inactivation and p16 immunohistochemistry in astrocytic gliomas.
Piva R; Cavalla P; Bortolotto S; Cordera S; Grosso R; Richiardi P; Dutto A; Schiffer D
Int J Oncol; 1998 Jan; 12(1):55-8. PubMed ID: 9454886
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
[TBL] [Abstract][Full Text] [Related]
25. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B
Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443
[TBL] [Abstract][Full Text] [Related]
26. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC
Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098
[TBL] [Abstract][Full Text] [Related]
27. Frequent mutation of p16 in squamous cell carcinoma of the head and neck.
Lang JC; Tobin EJ; Knobloch TJ; Schuller DE; Bartynski KJ; Mountain RE; Nicholson R; DeYoung BR; Weghorst CM
Laryngoscope; 1998 Jun; 108(6):923-8. PubMed ID: 9628511
[TBL] [Abstract][Full Text] [Related]
28. High frequency of p16INK4A gene alterations in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Chan JY; Hin LY; Lau WY; Lai PB; Lim BK; Huang J; Leung WT; Wu S; Lee JC
Oncogene; 1999 Jan; 18(3):789-95. PubMed ID: 9989830
[TBL] [Abstract][Full Text] [Related]
29. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.
Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y
Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987
[TBL] [Abstract][Full Text] [Related]
30. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
31. Lack of p16 gene mutations in gastric cancers in Kashmir.
Bashir SA; Pandith AA; Yousuf A; Parveen N; Siddiqi MA; Muddassar S; Andrabi KI; Abdin MZ
Asian Pac J Cancer Prev; 2010; 11(2):339-42. PubMed ID: 20843112
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas.
Esteve A; Martel-Planche G; Sylla BS; Hollstein M; Hainaut P; Montesano R
Int J Cancer; 1996 May; 66(3):301-4. PubMed ID: 8621247
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
34. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
Ibrahim SO; Lillehaug JR; Vasstrand EN
Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
[TBL] [Abstract][Full Text] [Related]
35. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa.
Gamieldien W; Victor TC; Mugwanya D; Stepien A; Gelderblom WC; Marasas WF; Geiger DH; van Helden PD
Int J Cancer; 1998 Nov; 78(5):544-9. PubMed ID: 9808520
[TBL] [Abstract][Full Text] [Related]
36. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.
Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K
Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248
[TBL] [Abstract][Full Text] [Related]
37. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
Ono Y; Tamiya T; Ichikawa T; Kunishio K; Matsumoto K; Furuta T; Ohmoto T; Ueki K; Louis DN
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1026-31. PubMed ID: 8857999
[TBL] [Abstract][Full Text] [Related]
38. [Study of deletion and mutation of p16 gene in primary hepatocellular carcinoma].
Qin Y; Chen J; Li B; Sun Z; Zuo F; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):492-4, 500. PubMed ID: 12528528
[TBL] [Abstract][Full Text] [Related]
39. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]